📊 Score Breakdown
Offering Ability
100
Cash Runway
95
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
61%
💰 Capital Raise
93%
• Critical: only 0.9 months cash remaining
• Active shelf registration ($1000M, 739% of market cap)
🔁 Convertible Conversion
40%
• Significant convertible debt: 21% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split
15%
• Only 1 months cash — financial pressure
💹 Market Data
Market Cap$135.23M
Shares Outstanding30.12M
Float21.92M
Cash$6.38M
Debt$127.78M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 9.4% shares (2025Q4 vs prior)
55 institutional holders · 9.82M shares
#1
Pantera Capital Partners LP
1.73M shares
#2
VANGUARD GROUP INC
1.26M shares
#3
SUSQUEHANNA INTERNATIONAL GROUP, LLP
813.5K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.67M
Days to Cover6.8
% of Float25.9%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
424B5
ATM
May 01, 2026
8-K
8K EVENT
May 01, 2026
EFFECT
EFFECT
Apr 27, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for DFDV
📊 DFDV FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 DFDV Signal Convergence & Dark Pool Activity — StonkWhisper
📄 DFDV Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.